Skip to main content
# Title Research Member Research Year
1 Sinopharm’s BBIBP-CorV Vaccine and ChAdOx1 nCoV-19 Vaccine Are Associated with a Comparable Immune Response against SARS-CoV-2 Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2022
2 Genetic variation in FOXP3 and ROR‑γ genes in pediatric acute lymphocytic leukemia (ALL) patients: correlation with associated cytokines Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2022
3 Evaluation of new markers of minimal residual disease in B acute lymphoblastic leukemia Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2022
4 Evaluation of new markers of minimal residual disease in B acute lymphoblastic leukemia Dr. Noha gaber sayed 2022
5 Evaluation of new markers of minimal residual disease in B acute lymphoblastic leukemia maureen raafat 2022
6 Combinatorial Therapy of Letrozole- and Quercetin-Loaded Spanlastics for Enhanced Cytotoxicity against MCF-7 Breast Cancer Cells Dr. Mohamed Galal Mostafa ELnaggar 2022
7 Risk of drug resistance and repeated infection with Klebsiella pneumoniae and Escherichia coli in intensive care unit cancer patients Dr. Iman Hassan Ahmed Hamada 2021
8 Higher CD19+ CD25+ Bregs are independently associated with better graft function in renal transplant recipients Dr. Iman Hassan Ahmed Hamada 2021
9 Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma Duaa Abdel-Samia Mohamed Ali 2021
10 Higher CD19+ CD25+ Bregs are independently associated with better graft function in renal transplant recipients Eman Hosny Mohammed Ibrahim 2021